Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Dickhoff

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Lung Cancer (Amsterdam, Netherlands)|October 10, 2024
Stereologic consequences of iatrogenic collapse: The morphology of adenocarcinoma in situ overlaps with invasive patterns. Proposal for a necessary modified classification of pulmonary adenocarcinomasFederica Filipello, Hans Blaauwgeers, Birgit Lissenberg-Witte, et al.
The Lancet Regional Health. Europe|March 13, 2024
New systemic treatment paradigms in resectable non-small cell lung cancer and variations in patient access across EuropeIlias Houda, Chris Dickhoff, Carin A Uyl-de Groot, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 29, 2025
Metastasectomy versus stereotactic body radiotherapy for patients with oligometastatic colorectal lung metastases: a systematic reviewSimone A Gooijer, Anna S M Gazendam, Bart Torensma, et al.
Journal of the National Cancer Institute|June 2, 2023
Bilaterality, not multifocality, is an independent risk factor for recurrence in low-risk papillary thyroid cancerPedro Manuel Rodriguez Schaap, Jia Feng Lin, Madelon J H Metman, et al.
European Journal of Cancer (Oxford, England : 1990)|October 8, 2025
Survival outcomes with carboplatin versus cisplatin and the impact of COVID-19 on platinum choice: A nationwide Netherlands registry study in small cell lung cancer patients (CACIS)Ilias Houda, Dwayne Naves, Ezgi B Ulas, et al.
The Lancet Regional Health. Europe|March 13, 2024
Challenges and controversies in resectable non-small cell lung cancer: a clinician's perspectiveIlias Houda, Chris Dickhoff, Carin A Uyl-de Groot, et al.
Journal for Immunotherapy of Cancer|November 28, 2025
Immune-modulating effects on tumor-draining lymph nodes of neoadjuvant chemoradiotherapy combined with dual immunotherapy in patients with T3-4N0-2 NSCLCEzgi B Ulas, Sofie J I Koomen, Anne Vrijmoet, et al.
Angiogenesis|August 20, 2020
Exacerbated inflammatory signaling underlies aberrant response to BMP9 in pulmonary arterial hypertension lung endothelial cellsRobert Szulcek, Gonzalo Sanchez-Duffhues, Nina Rol, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 27, 2022
Treatment patterns for adrenal metastases using surgery and SABR during a 10-year periodClaire van Vliet, Chris Dickhoff, Idris Bahce, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 8, 2024
Pharmacokinetic analysis and simplified uptake measures for tumour lesion [<sup>18</sup>F]F-AraG PET imaging in patients with non-small cell lung cancerJessica E Wijngaarden, Maarten Slebe, Johanna E E Pouw, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Lung Cancer (Amsterdam, Netherlands)|October 10, 2024
Stereologic consequences of iatrogenic collapse: The morphology of adenocarcinoma in situ overlaps with invasive patterns. Proposal for a necessary modified classification of pulmonary adenocarcinomasFederica Filipello, Hans Blaauwgeers, Birgit Lissenberg-Witte, et al.
The Lancet Regional Health. Europe|March 13, 2024
New systemic treatment paradigms in resectable non-small cell lung cancer and variations in patient access across EuropeIlias Houda, Chris Dickhoff, Carin A Uyl-de Groot, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 29, 2025
Metastasectomy versus stereotactic body radiotherapy for patients with oligometastatic colorectal lung metastases: a systematic reviewSimone A Gooijer, Anna S M Gazendam, Bart Torensma, et al.
Journal of the National Cancer Institute|June 2, 2023
Bilaterality, not multifocality, is an independent risk factor for recurrence in low-risk papillary thyroid cancerPedro Manuel Rodriguez Schaap, Jia Feng Lin, Madelon J H Metman, et al.
European Journal of Cancer (Oxford, England : 1990)|October 8, 2025
Survival outcomes with carboplatin versus cisplatin and the impact of COVID-19 on platinum choice: A nationwide Netherlands registry study in small cell lung cancer patients (CACIS)Ilias Houda, Dwayne Naves, Ezgi B Ulas, et al.
The Lancet Regional Health. Europe|March 13, 2024
Challenges and controversies in resectable non-small cell lung cancer: a clinician's perspectiveIlias Houda, Chris Dickhoff, Carin A Uyl-de Groot, et al.
Journal for Immunotherapy of Cancer|November 28, 2025
Immune-modulating effects on tumor-draining lymph nodes of neoadjuvant chemoradiotherapy combined with dual immunotherapy in patients with T3-4N0-2 NSCLCEzgi B Ulas, Sofie J I Koomen, Anne Vrijmoet, et al.
Angiogenesis|August 20, 2020
Exacerbated inflammatory signaling underlies aberrant response to BMP9 in pulmonary arterial hypertension lung endothelial cellsRobert Szulcek, Gonzalo Sanchez-Duffhues, Nina Rol, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 27, 2022
Treatment patterns for adrenal metastases using surgery and SABR during a 10-year periodClaire van Vliet, Chris Dickhoff, Idris Bahce, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 8, 2024
Pharmacokinetic analysis and simplified uptake measures for tumour lesion [<sup>18</sup>F]F-AraG PET imaging in patients with non-small cell lung cancerJessica E Wijngaarden, Maarten Slebe, Johanna E E Pouw, et al.
Pageof 9